Oral Oncology
Volume 39, Issue 7 , Pages 708-723 , October 2003

The effectiveness of community-based visual screening and utility of adjunctive diagnostic aids in the early detection of oral cancer

Received 13 January 2003 ,Accepted 23 January 2003.

References 

  1. Jemal A, Thomas A, Murray T, Thun M. Cancer Statistics, 2002. CA Cancer J Clin. 2002;52:23–47
  2. Swango PA. Cancers of the oral cavity and pharynx in the United States: an epidemiologic overview. J Public Health Dent. 1996;56:309–318
  3. Malaowalla AM, Silverman S, Mani NJ, Bilimoria KF, Smith LW. Oral cancer in 57,518 industrial workers of Gujarat, India: a prevalence and follow-up study. Cancer. 1976;37:1882–1886
  4. Mehta FS, Gupta PC, Bhonsle RB, Murti PR, Daftary DK, Pindborg JJ. Detection of oral cancer using basic health workers in an area of high oral cancer incidence in India. Cancer Detection Prevention. 1986;9:219–225
  5. Bouquot JE. Common oral lesions found during a mass screening examination. JADA. 1986;112:50–57
  6. Bouquot JE, Gorlin RJ. Leukoplakia, lichen planus, and other oral keratoses in 23,616 white Americans over the age of 35 years. Oral Surg Oral Med Oral Pathol. 1986;61:373–381
  7. Suggs TF, Cable TA, Rothenberger LA. Results of a work-site educational and screening program for hypertension and cancer. J Occupational Med. 1990;32:220–225
  8. Warnakulasuriya S, Pindborg JJ. Reliability of oral precancer screening by primary health care workers in Sri Lanka. Community Dent Health. 1990;7:73–79
  9. Banoczy J, Rigo O. Prevalence study of oral precancerous lesions within a complex screening system in Hungary. Community Dent Oral Epidemiol. 1991;19:265–267
  10. Ikeda N, Ishii T, Iida S, Kawai T. Epidemiological study of oral leukoplakia based on mass screening for oral mucosal diseases in a selected Japanese population. Community Dent Oral Epidemiol. 1991;19:160–163
  11. Talamini R, Barzan L, Franceschi S, Caruso G, Gasparin A, Comoretto R. Determinants of compliance with an early detection programme for cancer of the head and neck in North-eastern Italy. Eur J Cancer Part B, Oral Oncol. 1994;30B:415–418
  12. Field EA, Morrison T, Darling AE, Parr TA, Zakrzewska JM. Oral mucosal screening as an integral part of routine dental care. Br Dent J. 1995;179:262–266
  13. Ikeda N, Downer MC, Ishii T, Fukano H, Nagao T, Inoue K. Annual screening for oral cancer and precancer by invitation to 60-year-old residents of a city in Japan. Community Dental Health. 1995;12:133–137
  14. Fernandez Garrote L, Sankaranarayanan R, Lance Anta JJ, Rodriguez Salva A, Parkin DM. An evaluation of the oral cancer control program in Cuba. Epidemiology. 1995;6:428–431
  15. Jullien JA, Downer MC, Zakrzewska JM, Speight PM. Evaluation of a screening test for the early detection of oral cancer and precancer. Community Dental Health. 1995;12:3–7
  16. Jullien JA, Zakrzewska JM, Downer MC, Speight PM. Attendance and compliance at an oral cancer screening programme in a general medical practice. Eur J Cancer Part B, Oral Oncol. 1995;31B:202–206
  17. Downer MC, Evans AW, Hughes Hallet CM, Jullien JA, Speight PM, Zakrzewska JM. Evaluation of screening for oral cancer and precancer in a company headquarters. Community Dent Oral Epidemiol. 1995;23:84–88
  18. Mathew B, Wesley R, Dutt SC, Amma S, Sreekumar C. Cancer screening by local volunteers. World Health Forum. 1996;17:377–378
  19. Mathew B, Sankaranarayanan R, Sunilkumar KB, Kuruvila B, Pisani P, Nair MK. Reproducibility and validity of oral visual inspection by trained health workers in the detection of oral precancer and cancer. Brit J Cancer. 1997;76:390–394
  20. Burzynski NJ, Firriolo FJ, Butters JM, Sorrell CL. Evaluation of oral cancer screening. J Cancer Educ. 1997;12:95–99
  21. Prout MN, Sidari JN, Witzburg RA, Grillone GA, Vaughan CW. Head and neck cancer screening among 4611 tobacco users older than forty years. Otolaryngology Head Neck Surg. 1997;116:201–208
  22. Sankaranarayanan R, Mathew B, Jacob BJ, et al.  Early findings from a community-based, cluster-randomized, controlled oral cancer screening trial in Kerala, India. The Trivandrum Oral Cancer Screening Study Group. Cancer. 2000;88:664–673
  23. Nagao T, Ikeda N, Fukano H, Miyazaki H, Yano M, Warnakulasuriya S. Outcome following a population screening programme for oral cancer and precancer in Japan. Oral Oncol. 2000;36:340–346
  24. Nagao T, Warnakulasuriya S, Ikeda N, Fukano H, Fujiwara K, Miyazaki H. Oral cancer screening as an integral part of general health screening in Tokoname City, Japan. J Med Screen. 2000;7:203–208
  25. Vahidy NA, Zaidi SHM, Jafarey NA. Toluidine blue test for detection of carcinoma of the oral cavity: an evaluation. J Surg Oncol. 1972;4:434–438
  26. Mashberg A. Reevaluation of toluidine blue application as a diagnostic adjunct in the detection of asymptomatic oral squamous carcinoma. A continuing prospective study of oral cancer III. Cancer. 1980;46:758–763
  27. Mashberg A. Final evaluation of tolonium chloride rinse for screening of high-risk patients with asymptomatic squamous carcinoma. JADA. 1983;106:319–323
  28. Mashberg A. Tolonium (toluidine blue) rinse—a screening method for recognition of squamous carcinoma. Continuing study of oral cancer IV. JAMA. 1981;245:2408–2410
  29. Silverman S, Migliorati C, Barbosa J. Toluidine blue staining in the detection of oral precancerous and malignant lesions. Oral Surg Oral Med Oral Pathol. 1984;57:379–382
  30. Epstein JB, Scully C, Spinelli JJ. Toluidine blue and Lugol's iodine application in the assessment of oral malignant disease and lesions at risk of malignancy. J Oral Pathol Med. 1992;21:160–163
  31. Speight PM, Elliott AE, Jullien JA, Downer MC, Zakzrewska JM. The use of artificial intelligence to identify people at risk of oral cancer and precancer. Br Dent J. 1995;179:382–387
  32. Warnakulasuriya KA, Johnson NW. Sensitivity and specificity of OraScan (R) toluidine blue mouthrinse in the detection of oral cancer and precancer. J Oral Pathol Med. 1996;25:97–103
  33. Epstein JB, Oakley C, Millner A, Emerton S, van der Meij E, Le N. The utility of toluidine blue application as a diagnostic aid in patients previously treated for upper oropharyngeal carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997;83:537–547
  34. Sciubba JJ. US Collaborative OralCDx Study Group. Improving detection of precancerous and cancerous oral lesions. JADA. 1999;130:1445–1447
  35. Onofre MA, Sposto MR, Navarro CM. Reliability of toluidine blue application in the detection of oral epithelial dysplasia and in situ and invasive squamous cell carcinomas. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001;91:535–540
  36. Christian DC. Computer-assisted analysis of oral brush biopsies at an oral cancer screening program. JADA. 2002;133:357–362
  37. Moore C, Greenberg RA, Kane L. Feasibility study of a head and neck (upper aero-digestive tract) cancer examination. J Nat Cancer Institute. 1987;79:409–415
  38. van der Waal I, Axéll T. Oral leukoplakia: a proposal for uniform reporting. Oral Oncol. 2002;38:521–526
  39. Downer MC, Jullien JA, Speight PM. An interim determination of health gain from oral cancer and precancer screening: 2. developing a model of population screening. Community Dental Health. 1997;14:227–232
  40. Downer MC, Jullien JA, Speight PM. An interim determination of health gain from oral cancer and precancer screening: 3. preselecting high risk individuals. Community Dental Health. 1998;15:72–76
  41. Humphris GM, Ireland RS, Field EA. Randomised trial of the psychological effect of information about oral cancer in primary care settings. Oral Oncol. 2001;37:548–552
  42. Blot WJ, McLaughlin JK, Winn DM, et al.  Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res. 1988;48:3282–3287
  43. Shiboski CH, Shiboski SC, Silverman S. Trends in oral cancer rates in the United States, 1973–1996. Community Dent Oral Epidemiol. 2000;28:249–256
  44. Pandey M, Thomas G, Somanathanm T, et al.  Evaluation of surgical excision of non-homogeneous oral leukoplakia in a screening intervention trial, Kerala, India. Oral Oncol. 2001;37:103–109
  45. Lingen MW. Angiogenesis in the development of head and neck cancer and its inhibition by chemopreventive agents. Crit Rev Oral Biol Med. 1999;10:153–164
  46. Klaassen I, Braakhuis BJM. Anticancer activity and mechanism of action of retinoids in oral and pharyngeal cancer. Oral Oncol. 2002;38:532–542
  47. Papadimitrakopoulou VA, Clayman GL, Shin DM, et al.  Biochemoprevention for dysplastic lesions of the upper aerodigestive tract. Arch Otolaryngol Head Neck Surg. 1999;125:1083–1089
  48. Franceschi S, Bidoli E, Herrero R, Muñoz N. Comparison of cancers of the oral cavity and pharynx worldwide: etiological clues. Oral Oncol. 2000;36:106–115
  49. In:  Parkin DM,  Muir CS,  Whelan SL,  Gao Y-T,  Ferlay J,  Powell J editor. Cancer Incidence in Five Continents. Vol. 6 (IARC Scientific Publications No. 120). Lyon: International Agency for Research on Cancer; 1992;
  50. Sankaranarayanan R, Fernandez-Garrote L, Lence-Anta J, Pisani P, Rodriguez-Salva A. Visual inspection in oral cancer screening in Cuba: a case-control study. Oral Oncology. 2002;38:131–136
  51. Friedrich RE, Giese M, Riethdorf S, Loning T. P53-mutation in smears of oral squamous cell carcinoma. Anticancer Res. 2000;20:4927–4930
  52. Okazaki Y, Tanaka Y, Tonogi M, Yamane G. Investigation of environmental factors for diagnosing malignant potential in oral epithelial dysplasia. Oral Oncol. 2002;38:562–573
  53. Nunes DN, Kowalski LP, Simpson AJG. Detection of oral and oropharyngeal cancer by microsatellite analysis in mouth washes and lesion brushings. Oral Oncol. 2000;36:525–528
  54. Rosenberg D, Cretin S. Use of meta-analysis to evaluate tolonium chloride in oral cancer screening. Oral Surg Oral Med Oral Pathol. 1989;67:621–627

PII: S1368-8375(03)00083-6

doi: 10.1016/S1368-8375(03)00083-6

Oral Oncology
Volume 39, Issue 7 , Pages 708-723 , October 2003

Article Tools

* Image Usage & Resolution